Persistence with teriparatide in patients with osteoporosis: the UK experience

By Arden N.   Earl S.   Fisher D.   Cooper C.   Carruthers S.   Goater M.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1626-1629

Springer Publishing Company

Access to resources Recommend Favorite

Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica

By Moretti L.   Notarnicola A.   Panella A.   Garofalo L.   Garofalo R.   Santamato A.   Moretti B.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 1003-1006

Springer Publishing Company

Access to resources Recommend Favorite

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance

By Foster S.   Foley K.   Meadows E.   Johnston J.   Wang S.   Pohl G.   Long S.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 551-557

Springer Publishing Company

Access to resources Recommend Favorite

Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis

By Lasco A.   Catalano A.   Morabito N.   Gaudio A.   Basile G.   Trifiletti A.   Atteritano M.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 299-303

Springer Publishing Company

Access to resources Recommend Favorite

Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice

By Ish-Shalom Sophia   Dumitrache Constantin   El-Husseini Timour Fikry   Hussein Azza   Barker Clare   Pavo Imre  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 343-353

Informa Healthcare

Access to resources Recommend Favorite